Second- and Further-Line Therapy with Erlotinib in Patients with Advanced Non-Small-Cell Lung Cancer in Daily Clinical Practice

by Josephine Krainhöfer, Mario Walther, Matthias Steinert, Angelika Reissig
Published 2014-01-01